Austin Fertility & Reproductive Medicine/Westlake IVF has an article, “Serum Antimüllerian hormone does not predict elevated progesterone levels among women who undergo controlled ovarian hyperstimulation for in vitro fertilization”, published in the journal Reproductive Biology and Endocrinology, April 2019.

“We were interested in investigating whether or not the ovarian reserve biomarker, antimüllerian hormone (AMH), can predict an elevated progesterone level, defined as a progesterone level greater than or equal to 1.5 ng/mL, on the day of trigger prior to oocyte retrieval in IVF patients,” states Dr. Shahryar Kavoussi. “Our retrospective study suggests that an AMH is not a predictor of elevated serum progesterone on the day of trigger in IVF patients”.

Read the article’s abstract

Read the article